STOCKHOLDERS' EQUITY AND EARNINGS PER SHARE (Tables)

12 Months Ended

Dec. 31, 2018

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Stockholders Equity

Our capital structure consisted of the following at December 31, 2018 and 2017:

		December 31,
		2018		2017
	Authorized	Total Issued		Total Issued
Common Stock
Common Stock	150,208,500	1,772,894		1,255,642
Class B Common Stock:
Class B-1	4,023,400	3,811,342		3,811,342
Class B-2	4,023,400	3,811,342		3,811,342
Class B-3	8,165,700	7,735,169		7,735,169
Class B-4	781,644	627,579		627,579
Total Class B Common Stock	16,994,144	15,985,432		15,985,432
Class C Common Stock	15,803,212	838,448		838,448
Class D Common Stock	16,994,144	—		—
Total Common Stock	200,000,000	18,596,774		18,079,522
Preferred Stock
Series B Cumulative Convertible	100,000,000	10,552,941		8,200,000
Series A Redeemable	—	22,000		—
Total Preferred Stock	100,000,000	10,574,941		8,200,000
Total	300,000,000	29,171,715		26,279,522
Less: Treasury Stock		(1,870,164	)	(1,826,096	)
Total issued and outstanding		27,301,551		24,453,426

Fair Value Inputs, Instruments Classified in Shareholders' Equity, Quantitative Information

For stock options issued during the years ended December 31, 2018 and 2017, the fair value was estimated at the date of grant using the Black-Scholes option-pricing model based on the exercise price of the award and other assumptions relating to expected dividend yield, expected stock price volatility, risk-free interest rate, and expected life of options granted which were as follows:

	December 31,
	2018		2017
Expected stock price volatility	40	%	69	%
Risk-free interest rate	2	%	2	%
Expected life of options (years)	5.5		6
Expected dividend yield	0		0
Discount for lack of marketability	25	%	35	%

Schedule of Share-based Compensation, Stock Options, Activity

A summary of stock option and restricted stock activity as of and for the years ended December 31, 2018 and 2017, is presented below:

	Stock Options								Restricted Stock
Outstanding At	Shares		Exercise Price Per Share			Remaining Contractual Term (in years)	Aggregate Intrinsic Value (in millions)		Time-Based Restricted Shares
December 31, 2016	938,667		$	6.10		3.1	$	—	889,456
Granted	116,830		1.13			—	—		469,097
Exercised or vested	—		—			—	—		(567,043	)
Forfeited or expired	—		—			—	—		—
December 31, 2017	1,055,497		6.74			0.3	—		791,510
Granted	110,979		2.42			—	—		249,496
Exercised or vested	—		—			—	—		(517,252	)
Forfeited or expired	(63,849	)	(6.52		)	—	—		—
December 31, 2018	1,102,627		$	5.25		1.63	$	—	523,754

Schedule of Earnings Per Share, Basic and Diluted

The following table presents a reconciliation of net loss to net loss attributable to common shareholders used in the basic and diluted earnings per share calculations for the years ended December 31, 2018 and 2017 (amounts in thousands, except for per share data):

	Years Ended December 31,
	2018			2017
Earnings allocable to common shares:
Numerator - Loss Attributable to Common Shareholders:
Net loss	$	(12,197	)	$	(4,626	)
Net income (loss) attributable to non-controlling interest	(1,144		)	798
Preferred dividends	(7,229		)	(4,856		)
Net loss from continuing operations attributable to common shareholders	(20,570		)	(8,684		)
Net income from discontinued operations	—			3,071
Net loss attributable to common shareholders	$	(20,570	)	$	(5,613	)
Denominator - Weighted average shares:
Weighted average common shares outstanding for basic and diluted earnings per common share	16,703,866			16,188,250
Basic and diluted earnings per common share:
Net loss per share	(0.80		)	(0.24		)
Preferred dividends per share	(0.43		)	(0.30		)
Net loss per share, continuing operations, net	(1.23		)	(0.54		)
Net loss per share, discontinued operations	—			0.19
Net loss attributable to common shareholder per share	(1.23		)	(0.35		)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following securities were not included in the computation of diluted net loss per share as their effect would have been anti-dilutive (presented on a weighted average balance):

	Years Ended December 31,
	2018	2017
Options to purchase common stock	1,085,497	993,401
Restricted stock	318,390	640,668
Warrants to purchase common stock	2,600,000	2,000,000
Convertible preferred stock	10,552,941	8,200,000
Total	14,556,828	11,834,069